Public Health
Volume 123, Issue 8 , Pages 540-544 , August 2009

Type 2 diabetes mellitus associated with increased risk for colorectal cancer: Evidence from an international ecological study and population-based risk analysis in China

  • X. Ren

      Affiliations

    • Department of Epidemiology and Biostatistics, Zhejiang University School of Medicine, 388 Yu-Hang-Tang Road, Hangzhou 310058, Zhejiang, PR China
    • ,
  • X. Zhang

      Affiliations

    • Department of Epidemiology and Biostatistics, Zhejiang University School of Medicine, 388 Yu-Hang-Tang Road, Hangzhou 310058, Zhejiang, PR China
    • ,
  • X. Zhang

      Affiliations

    • Department of Epidemiology and Biostatistics, Zhejiang University School of Medicine, 388 Yu-Hang-Tang Road, Hangzhou 310058, Zhejiang, PR China
    • Hangzhou Centers of Disease Prevention and Control, Hangzhou 31006, PR China
    • ,
  • W. Gu

      Affiliations

    • Jiaxing Centers of Disease Prevention and Control, Jiaxing 314050, PR China
    • ,
  • K. Chen

      Affiliations

    • Department of Epidemiology and Biostatistics, Zhejiang University School of Medicine, 388 Yu-Hang-Tang Road, Hangzhou 310058, Zhejiang, PR China
    • ,
  • Y. Le

      Affiliations

    • Department of Epidemiology and Biostatistics, Zhejiang University School of Medicine, 388 Yu-Hang-Tang Road, Hangzhou 310058, Zhejiang, PR China
    • ,
  • M. Lai

      Affiliations

    • Center for Environmental Genomics, Zhejiang University School of Medicine, Hangzhou 310058, Zhejiang, PR China
    • ,
  • Y. Zhu

      Affiliations

    • Department of Epidemiology and Biostatistics, Zhejiang University School of Medicine, 388 Yu-Hang-Tang Road, Hangzhou 310058, Zhejiang, PR China
    • Corresponding Author InformationCorresponding author. Tel.: +86 571 88208362; fax: +86 571 88208198.

Received 12 February 2009 ,Revised 1 June 2009 ,Accepted 26 June 2009.

References 

  1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047–1053
  2. Chen K, Lindsey JB, Khera A, De Lemos JA, Ayers CR, Goyal A, et al. Independent associations between metabolic syndrome, diabetes mellitus and atherosclerosis: observations from the Dallas Heart Study. Diab Vasc Dis Res. 2008;5:96–101
  3. Metcalf PA, Wells S, Scragg RK, Jackson R. Comparison of three different methods of assessing cardiovascular disease risk in New Zealanders with type 2 diabetes mellitus. N Z Med J. 2008;121:49–57
  4. Schindler TH, Facta AD, Prior JO, Cadenas J, Zhang XL, Li Y, et al. Structural alterations of the coronary arterial wall are associated with myocardial flow heterogeneity in type 2 diabetes mellitus. Eur J Nucl Med Mol Imaging. 2008;
  5. Fox CS, Muntner P. Trends in diabetes, high cholesterol, and hypertension in chronic kidney disease among U.S. adults: 1988–1994 to 1999–2004. Diabetes Care. 2008;31:1337–1342
  6. Engelgau MM, Geiss LS, Saaddine JB, Boyle JP, Benjamin SM, Gregg EW, et al. The evolving diabetes burden in the United States. Ann Intern Med. 2004;140:945–950
  7. Tran TT, Gupta N, Goh T, Naigamwalla D, Chia MC, Koohestani N, et al. Direct measure of insulin sensitivity with the hyperinsulinemic-euglycemic clamp and surrogate measures of insulin sensitivity with the oral glucose tolerance test: correlations with aberrant crypt foci promotion in rats. Cancer Epidemiol Biomarkers Prev. 2002;12:47–56
  8. Tran TT, Medline A, Bruce WR. Insulin promotion of colon tumors in rats. Cancer Epidemiol Biomarkers Prev. 1996;5:1013–1015
  9. Shao L, Huang Q, Luo M, Lai M. Detection of the differentially expressed gene IGF-binding protein-related protein-1 and analysis of its relationship to fasting glucose in Chinese colorectal cancer patients. Endocr Relat Cancer. 2004;11:141–148
  10. Kaaks R, Toniolo P, Akhmedkhanov A, Lukanova A, Biessy C, Dechaud H, et al. Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women. J Natl Cancer Inst. 2000;92:1592–1600
  11. Palmqvist R, Stattin P, Rinaldi S, Biessy C, Stenling R, Riboli E, et al. Plasma insulin, IGF-binding proteins-1 and -2 and risk of colorectal cancer: a prospective study in northern Sweden. Int J Cancer. 2003;107:89–93
  12. Larsson SC, Orsini N, Wolk A. Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst. 2005;97:1679–1687
  13. Oba S, Nagata C, Nakamura K, Takatsuka N, Shimizu H. Self-reported diabetes mellitus and risk of mortality from all causes, cardiovascular disease, and cancer in Takayama: a population-based prospective cohort study in Japan. J Epidemiol. 2008;18:197–203
  14. Larsson SC, Mantzoros CS, Wolk A. Diabetes mellitus and risk of breast cancer: a meta-analysis. Int J Cancer. 2007;121:856–862
  15. Larsson SC, Orsini N, Brismar K, Wolk A. Diabetes mellitus and risk of bladder cancer: a meta-analysis. Diabetologia. 2006;49:2819–2823
  16. Pierce BL, Plymate S, Ostrander EA, Stanford JL. Diabetes mellitus and prostate cancer risk. Prostate. 2008;68:1126–1132
  17. Rubenstein JH, Davis J, Marrero JA, Inadomi JM. Relationship between diabetes mellitus and adenocarcinoma of the oesophagus and gastric cardia. Aliment Pharmacol Ther. 2005;22:267–271
  18. Smith MR, Bae K, Efstathiou JA, Hanks GE, Pilepich MV, Sandler HM, et al. Diabetes and mortality in men with locally advanced prostate cancer: RTOG 92-02. J Clin Oncol. 2008;26:4333–4339
  19. Torisu Y, Ikeda K, Kobayashi M, Hosaka T, Sezaki H, Akuta N, et al. Diabetes mellitus increases the risk of hepatocarcinogenesis in patients with alcoholic cirrhosis: a preliminary report. Hepatol Res. 2007;37:517–523
  20. Limburg PJ, Anderson KE, Johnson TW, Jacobs DR, Lazovich D, Hong CP, et al. Diabetes mellitus and subsite-specific colorectal cancer risks in the Iowa Women's Health Study. Cancer Epidemiol Biomarkers Prev. 2005;14:133–137
  21. Hu FB, Manson JE, Liu S, Hunter D, Colditz GA, Michels KB, et al. Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women. J Natl Cancer Inst. 1999;91:542–547
  22. Weiderpass E, Ye W, Vainio H, Kaaks R, Adami HO. Reduced risk of prostate cancer among patients with diabetes mellitus. Int J Cancer. 2002;102:258–261
  23. Pan XR, Yang WY, Li GW, Liu J. Prevalence of diabetes and its risk factors in China, 1994. National Diabetes Prevention and Control Cooperative Group. Diabetes Care. 1997;20:1664–1669
  24. Aspray TJ, Mugusi F, Rashid S, Whiting D, Edwards R, Alberti KG, et al. Rural and urban differences in diabetes prevalence in Tanzania: the role of obesity, physical inactivity and urban living. Trans R Soc Trop Med Hyg. 2000;94:637–644
  25. Jin T. Why diabetes patients are more prone to the development of colon cancer?. Med Hypotheses. 2008;71:241–244
  26. World Health Organization . Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Part 1. Diagnosis and classification of diabetes mellitus. Geneva: World Health Organization; 1999;
  27. Yang YX, Hennessy S, Lewis JD. Type 2 diabetes mellitus and the risk of colorectal cancer. Clin Gastroenterol Hepatol. 2005;3:587–594
  28. Brauer PM, McKeown-Eyssen GE, Jazmaji V, Logan AG, Andrews DF, Jenkins D, et al. Familial aggregation of diabetes and hypertension in a case-control study of colorectal neoplasia. Am J Epidemiol. 2002;156:702–713
  29. Elwing JE, Gao F, Davidson NO, Early DS. Type 2 diabetes mellitus: the impact on colorectal adenoma risk in women. Am J Gastroenterol. 2006;101:1866–1871
  30. Limburg PJ, Vierkant RA, Fredericksen ZS, Leibson CL, Rizza RA, Gupta AK, et al. Clinically confirmed type 2 diabetes mellitus and colorectal cancer risk: a population-based, retrospective cohort study. Am J Gastroenterol. 2006;101:1872–1879
  31. Seow A, Yuan JM, Koh WP, Lee HP, Yu MC. Diabetes mellitus and risk of colorectal cancer in the Singapore Chinese Health Study. J Natl Cancer Inst. 2006;98:135–138
  32. Weiderpass E, Gridley G, Nyren O, Ekbom A, Persson I, Adami HO. Diabetes mellitus and risk of large bowel cancer. J Natl Cancer Inst. 1997;89:660–661
  33. Harris MI, Eastman RC. Early detection of undiagnosed diabetes mellitus: a US perspective. Diabetes Metab Res Rev. 2000;16:230–236
  34. Bufill JA. Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location. Ann Intern Med. 1990;113:779–788
  35. Distler P, Holt PR. Are right- and left-sided colon neoplasms distinct tumors?. Dig Dis. 1997;15:302–311
  36. Schoen RE, Weissfeld JL, Kuller LH, Thaete FL, Evans RW, Hayes RB, et al. Insulin-like growth factor-I and insulin are associated with the presence and advancement of adenomatous polyps. Gastroenterology. 2005;129:464–475
  37. Sandhu MS, Dunger DB, Giovannucci EL. Insulin, insulin-like growth factor-I (IGF-I), IGF binding proteins, their biologic interactions, and colorectal cancer. J Natl Cancer Inst. 2002;94:972–980
  38. Wu X, Zhao H, Do KA, Johnson MM, Dong Q, Hong WK, et al. Serum levels of insulin growth factor (IGF-I) and IGF-binding protein predict risk of second primary tumors in patients with head and neck cancer. Clin Cancer Res. 2004;10:3988–3995
  39. Yu H, Spitz MR, Mistry J, Gu J, Hong WK, Wu X. Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control analysis. J Natl Cancer Inst. 1999;91:151–156
  40. Landman GW, Ubink-Veltmaat LJ, Kleefstra N, Kollen BJ, Bilo HJ. Increased cancer mortality in type 2 diabetes (ZODIAC-3). Anticancer Res. 2008;28:1373–1375

PII: S0033-3506(09)00172-3

doi: 10.1016/j.puhe.2009.06.019

Public Health
Volume 123, Issue 8 , Pages 540-544 , August 2009

Article Tools

* Image Usage & Resolution